Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $5.2200 (-1.14%) ($5.2200 - $5.2200) on Tue. Apr. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.07% (three month average) | RSI | 46 | Latest Price | $5.2200(-1.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.1% a day on average for past five trading days. | Weekly Trend | AUTL declines -3.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) BNDX(12%) TLT(11%) BND(9%) XLRE(9%) LQD(7%) | Factors Impacting AUTL price | AUTL will decline at least -2.035% in a week (0% probabilities). TBT(-11%) UNG(-8%) USO(-6%) XLF(-5%) EDOC(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.035% (StdDev 4.07%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.09(-178.35%) | Resistance Level | $5.67 | 5 Day Moving Average | $5.38(-2.97%) | 10 Day Moving Average | $5.49(-4.92%) | 20 Day Moving Average | $5.67(-7.94%) | To recent high | -41.3% | To recent low | 0% | Market Cap | $273m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |